These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38970559)

  • 21. Growth hormone status following treatment for Cushing's syndrome.
    Hughes NR; Lissett CA; Shalet SM
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):61-6. PubMed ID: 10468966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycated albumin is set lower in relation to plasma glucose levels in patients with Cushing's syndrome.
    Kitamura T; Otsuki M; Tamada D; Tabuchi Y; Mukai K; Morita S; Kasayama S; Shimomura I; Koga M
    Clin Chim Acta; 2013 Sep; 424():164-7. PubMed ID: 23792199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of single doses of dexamethasone and adrenocorticotrop hormone on serum bone markers in healthy subjects and in patients with adrenal incidentalomas and Cushing's syndrome.
    Majnik J; Szücs N; Patócs A; Tóth M; Balogh K; Varga I; Gláz E; Rácz K
    J Endocrinol Invest; 2004 Sep; 27(8):747-53. PubMed ID: 15636428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The corticotropin-releasing-hormone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing's syndrome.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    Lancet; 1986 Sep; 2(8506):540-4. PubMed ID: 2875282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cushing's syndrome: comparison between Cushing's disease and adrenal Cushing's.
    Hirsch D; Shimon I; Manisterski Y; Aviran-Barak N; Amitai O; Nadler V; Alboim S; Kopel V; Tsvetov G
    Endocrine; 2018 Dec; 62(3):712-720. PubMed ID: 30084101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subclinical Cushing's syndrome in adrenal incidentaloma.
    Terzolo M; Osella G; Alì A; Borretta G; Cesario F; Paccotti P; Angeli A
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression of angiotensin II receptor in blood cells of Cushing's syndrome.
    Shibata H; Suzuki H; Maruyama T; Saruta T
    Hypertension; 1995 Dec; 26(6 Pt 1):1003-10. PubMed ID: 7490136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A putative role for the aryl hydrocarbon receptor (AHR) gene in a patient with cyclical Cushing's disease.
    De Sousa SMC; Manavis J; Feng J; Wang P; Schreiber AW; Scott HS; Torpy DJ
    BMC Endocr Disord; 2020 Jan; 20(1):18. PubMed ID: 31996203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor.
    Morio H; Terano T; Yamamoto K; Tomizuka T; Oeda T; Saito Y; Tamura Y; Sasano H
    Endocr J; 1996 Aug; 43(4):387-96. PubMed ID: 8930526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum albumin-adjusted glycated albumin is an adequate indicator of glycemic control in patients with Cushing's syndrome.
    Kitamura T; Otsuki M; Tamada D; Tabuchi Y; Mukai K; Morita S; Kasayama S; Bando Y; Shimomura I; Koga M
    Clin Biochem; 2014 Dec; 47(18):279-82. PubMed ID: 25218816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nocturnal 8 mg dexamethasone suppression test: a practical and accurate test for identification of the cause of endogenous Cushing's syndrome.
    Sriussadaporn S; Ploybutr S; Peerapatdit T; Plengvidhya N; Nitiyanant W; Vannasaeng S; Vichayanrat A
    Br J Clin Pract; 1996; 50(1):9-13. PubMed ID: 8729595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Median 10 years follow-up of patients with covert Cushing's syndrome: a case series.
    Najafipour F; Bahrami A; Niafar M; Houshyar J; Halimi M; Sadra V
    J Med Case Rep; 2021 Oct; 15(1):514. PubMed ID: 34635153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome.
    Kola B; Christ-Crain M; Lolli F; Arnaldi G; Giacchetti G; Boscaro M; Grossman AB; Korbonits M
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4969-73. PubMed ID: 18782871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of markers of bone and collagen turnover in patients with active and preclinical Cushing's syndrome and in patients with adrenal incidentaloma.
    Sartorio A; Conti A; Ferrero S; Giambona S; Re T; Passini E; Ambrosi B
    Eur J Endocrinol; 1998 Feb; 138(2):146-52. PubMed ID: 9506857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome.
    N'Diaye N; Tremblay J; Hamet P; De Herder WW; Lacroix A
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2781-5. PubMed ID: 9709947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome.
    Findling JW; Kehoe ME; Shaker JL; Raff H
    J Clin Endocrinol Metab; 1991 Aug; 73(2):408-13. PubMed ID: 1649842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.